Chemokine (C-C motif) ligand 2 (CCL2) in sera of patients with type 1 diabetes and diabetic complications. - Wikidata - awgldk - TriplyDB

Chemokine (C-C motif) ligand 2 (CCL2) in sera of patients with type 1 diabetes and diabetic complications.

Chemokine (C-C motif) ligand 2 (CCL2) in sera of patients with type 1 diabetes and diabetic complications.

http://www.wikidata.org/entity/Q33885832

about

Transcriptional regulation of chemokine genes: a link to pancreatic islet inflammation?Pancreatic islet expression of chemokine CCL2 suppresses autoimmune diabetes via tolerogenic CD11c+ CD11b+ dendritic cells Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1β in Patients With Type 1 Diabetes.Novel biomarkers in type 1 diabetes.Luminex and other multiplex high throughput technologies for the identification of, and host response to, environmental triggers of type 1 diabetes.Redox control of indoleamine 2,3-dioxygenase expression and activity in human monocyte-derived dendritic cells is independent of changes in oxygen tension.CCR2 upregulation in DRG neurons plays a crucial role in gastric hyperalgesia associated with diabetic gastropathy.Type 1 Diabetes: A Chronic Anti-Self-Inflammatory Response.Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story.

P2860

Q27009030-1E647D44-1E85-4E1D-A7B9-3568BC08D298 Q35807532-1EB2B228-CD3A-407F-9571-7C0FC1A9A05B Q36060484-788D4CBF-1AD2-42E7-9D1A-28398BC46397 Q37088197-F80CCA3D-281F-489F-A1D0-90A4FF65C2D4 Q38425675-BD5088D0-5C94-43BE-8490-F7D3ED8BE2E3 Q44995189-258521B9-30B5-435B-9313-C8EFA33D7D0B Q48187127-A6922C6A-8D21-42BC-8DF8-63644E95B105 Q49200196-B2C3AB51-FE8A-435D-9B5F-7CC854AD553F Q52650664-272571FA-98A8-4034-ABB3-1D3C2C2FFBBE

P2860

Chemokine (C-C motif) ligand 2 (CCL2) in sera of patients with type 1 diabetes and diabetic complications.

http://www.wikidata.org/entity/Q33885832

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Chemokine (C-C motif) ligand 2 ...... es and diabetic complications.

@ast

Chemokine (C-C motif) ligand 2 ...... es and diabetic complications.

@en

type

label

Chemokine (C-C motif) ligand 2 ...... es and diabetic complications.

@ast

Chemokine (C-C motif) ligand 2 ...... es and diabetic complications.

@en

prefLabel

Chemokine (C-C motif) ligand 2 ...... es and diabetic complications.

@ast

Chemokine (C-C motif) ligand 2 ...... es and diabetic complications.

@en

P1433

Q33885832-57AB7D88-49B1-436E-A471-BB6D6E7CD7D7

P1476

Q33885832-3E3D972F-CF63-4978-86A8-0D3E178FC5E7

P2093

Q33885832-0E6D0025-C732-4E39-8678-70B3AD54D8AC

Q33885832-1364666C-26E6-4A42-A75E-CA11439A4F1B

Q33885832-264319B5-1F79-485F-B57E-0357E0F0C5CD

Q33885832-4431885B-63CD-414F-A898-6E25D83D90E4

Q33885832-46A99543-B638-4748-B2E0-5FCC5140C409

Q33885832-6B9E0185-2725-4AFC-AC4B-2416A4840BD4

Q33885832-86F0401C-DDAC-4B85-9281-1192251B7F0B

Q33885832-9200A87C-D608-4FEA-8A80-3EFD5A346F10

Q33885832-A098B6F5-8C69-4838-B7F5-9AAE6441A586

Q33885832-FC06ABC7-2809-4F29-A9C5-1F7B04391269

P2860

Q33885832-082EE374-7C03-4609-8A7D-6FF5B5825049

Q33885832-0F25DE2B-4F21-4D7B-9835-E5CCCE237C74

Q33885832-101C2029-578B-4085-9B53-120D1A9BE279

Q33885832-1793C3F6-7889-4BE6-A51D-8427070E3321

Q33885832-45810B0A-3596-485C-B91D-030F4E09096C

Q33885832-4B6F1152-F1CF-45E3-81CF-1F93EE312412

Q33885832-51CD8C73-FB82-4AF0-8BF2-8999C60FD39A

Q33885832-5426A3B2-A293-47A9-8C68-68C76438BD68

Q33885832-566A23AF-4846-44F4-B1A9-03611E1EDB72

Q33885832-61F74173-1229-437A-8A3D-FDBCD2B0C85A

P304

Q33885832-605DCE36-DCB8-40CA-8F25-001AE4612243

P31

Q33885832-2AB5A52F-98E7-416F-95F1-8C4E1D3F49DE

P356

Q33885832-ED37AE9E-67A9-4467-802A-E27F6101A8C6

P407

Q33885832-34BD434F-1099-4B8D-945E-2BC87D03C58A

P433

Q33885832-A527C896-5B46-4782-9B3E-B4B5B0797B53

P478

Q33885832-66F3C4F7-AE64-44B7-A33C-CC3685B56986

P577

Q33885832-80A9B547-A462-42E8-BC48-0B14B1B918A7

P5875

Q33885832-DC12592D-4B34-4C2F-88CB-5CDA36CB8CF4

P698

Q33885832-BEFB8B43-E845-41C3-8C00-B5D061591912

P921

Q33885832-AB48B1B0-DE1F-49FB-ACC9-85B3C9DB3CBD

P932

Q33885832-5A2D9542-0A23-4150-B936-299F02742692

P356

JOURNAL.PONE.0017822

P1433

P1476

Chemokine (C-C motif) ligand 2 ...... es and diabetic complications.

@en

P2093

Bruce Bode

http://www.w3.org/2001/XMLSchema#string

Chun Xia

http://www.w3.org/2001/XMLSchema#string

Diane Hopkins

http://www.w3.org/2001/XMLSchema#string

Hongjie Wang

http://www.w3.org/2001/XMLSchema#string

Jin-Xiong She

http://www.w3.org/2001/XMLSchema#string

John Chip Reed

http://www.w3.org/2001/XMLSchema#string

Leigh Steed

http://www.w3.org/2001/XMLSchema#string

R Dennis Steed

http://www.w3.org/2001/XMLSchema#string

Ruili Guan

http://www.w3.org/2001/XMLSchema#string

Sharad Purohit

http://www.w3.org/2001/XMLSchema#string

P2860

Serum monocyte chemoattractant protein-1 concentrations associate with diabetes status but not arterial stiffness in children with type 1 diabetes

Imbalance in Th cell polarization and its relevance in type 1 diabetes mellitus

Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice.

MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy.

IFIH1 polymorphisms are significantly associated with type 1 diabetes and IFIH1 gene expression in peripheral blood mononuclear cells.

Effect of the monocyte chemoattractant protein-1/CC chemokine receptor 2 system on nephrin expression in streptozotocin-treated mice and human cultured podocytes.

Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals.

Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression.

Alpha-chemokine CXCL10 and beta-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis.

In vivo properties of monocyte chemoattractant protein-1.

P304

e17822

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0017822

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51088952

http://www.w3.org/2001/XMLSchema#string

P698

21532752

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

3075244

http://www.w3.org/2001/XMLSchema#string